Non-intravitreal anti-vascular endothelial growth factor delivery for ocular neovascular diseases: Current status and future directions
{{output}}
Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has fundamentally transformed the management of retinal and choroidal neovascular diseases. Despite its proven efficacy, long-term reliance on repeated intravitreal injections imposes a substa... ...